Ono Pharma selects Medidata Rave solution

Medidata Rave will improve operational efficiency and enhance workflow throughout the clinical trial process.

The company also selected Medidata to develop candidate compounds for new drugs and actively conduct trials outside of Japan.

Ono Pharmaceutical Data Science director Satoru Fukinbara said Medidata’s established network of satisfied and successful sponsors, in addition to a strong support team, gives them access to a wealth of knowledge and best practices that can help guide their efforts in global expansion.

Ono Pharmaceutical is engaged in drug discovery research based on accumulated technologies.

Medidata Solutions is a global provider of SaaS clinical development solutions that enhance the efficiency of customers’ clinical trials.